PLOS is a non-profit organization on a mission to drive open science forward with measurable, meaningful change in research publishing, policy, and practice.

Building on a strong legacy of pioneering innovation, PLOS continues to be a catalyst, reimagining models to meet open science principles, removing barriers and promoting inclusion in knowledge creation and sharing, and publishing research outputs that enable everyone to learn from, reuse and build upon scientific knowledge.

We believe in a better future where science is open to all, for all.

Journals
More Content
PLOS BLOGS Speaking of Medicine and Health
Browse all PLOS Blogs
Browse all PLOS Blogs

This week in PLoS Medicine: HIV and noncommunicable diseases hinder the progress of poor countries’ MDGs; New treatments for stroke will benefit from genetic research

PLOS General

Read the new papers published in PLoS Medicine this week, including a Research Article that examines why poor countries are falling behind with the UN Millennium Development Goals for health and finds that noncommunicable diseases and HIV prevalence are strongly associated with the difficulty countries have meeting these targets.

Also published this week, two Research in Translation articles discussing advancements in the treatment of stroke: The first discusses the next generation of stroke treatments and says that novel therapeutic targets may emerge from the stimulation of neuroplasticity and unraveling the genetic code of stroke heterogeneity. The second describes the genetic factors in stroke risk and emphasizes the importance of large sample studies and rigorous replication of results in genetic stroke research.

You can comment on, annotate, and rate this week’s PLoS Medicine articles and any of the others in the archive.

Back to top